Purpose: To develop a model for the identification of early symptomatic knee osteoarthritis (OA) based on clinical, x-ray and biomarker variables using MRI as the gold standard in a population based study. Methods: Subjects, 40-79 years, with knee pain were assembled, stratified by age decade and gender, in a cross-sectional population-based study and evaluated clinically, with MRI, x-ray and biomarkers. MR cartilage (MRC) defects were scored 0-4 on 6 knee joint surfaces with subsequent application of a weighted MRC (wMRC) score, which reflects the mean depth of a given cartilage defect (MRC 0 or 1 = wMRC 0, MRC 2 = wMRC 0.25, MRC 3 = wMRC 0.75, MRC 4 = wMRC 1.0). The sum of all wMRC scores was used to determine the total knee score. Subjects were classified as No OA (NOA) (total knee score = 0), early OA (EOA) (total knee score 0.1-1.9) or advanced OA (AOA) (total knee score ≥ 2). X-rays were read using Kellgren-Lawrence [KL] 0-4 grading. Biomarkers (Bio) were log transformed and included serum and urine C2C and C1,2C, 846 epitope, CPII, CTX-II, COMP and hyaluronic acid. Clinical variables assessed in the models were age, gender, body mass index (BMI), alignment, gait, quadriceps atrophy, effusion and crepitus. A continuationratio ordinal regression model was used to simultaneously model 2 binary responses (normal versus non-normal; early versus advanced OA assuming abnormality is present) that represent two stages of disease progression. Partial proportional odds ratios were used to allow for different effects of a variable in the 2 stages. A bootstrap-based approach was adapted for variable selection. Models were evaluated based on prediction accuracy, Akaike's Information Criterion (AIC), where a lower value indicates a better model fit, and the C-index, where a 1.0 score indicates a perfect model fit. All reported results are adjusted for stratum sampling weights. Results: Of 255 subjects, 33 (13%) had NOA, 106 (43%) had EOA, 116 (44%) had AOA. The ability of different models to identify NOA, EOA and AOA is summarized in Table 1 . The variables that were selected in the Clinical+Xray+Bio model were age, gender, BMI, effusion, gait, quadriceps atrophy, KL grade, urine CTX-II, serum CPII/C2C, and urine C2C. Conclusions: While the addition of x-ray to the clinical model enhances prediction for early and advanced OA, but not No OA, the addition of biomarkers improves the prediction of No OA dramatically. In this population-based study, we conclude that people with knee pain can be classified into different subgroups of OA
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Results: BMI was a strong risk factor for knee and hip OA with obesity (BMI ≥30 kg/m 2 ) showing greater risk than overweight (BMI ≥25<30 kg/m 2 ). The risk was greater for knee than hip OA, and greater for women than men at the knee. All trends were significant at p<0.001 after adjustment for confounders. An increasing risk (p<0.001) was observed for hip and knee OA with duration of being overweight (never, current, middle age onwards, always). This risk was greater for women than men, e.g. in the always overweight group women (OR=14.2 (8.1-24.9) versus men (OR=4.1 (2.7-6.3)). There was a risk associated with increasing waist-hip ratio (WHR) (knees OR=1.7 (1.4-2.1), hip OR=1.6 (1.3-2.0) both p<0.001), which was lost after adjustment for BMI. A similar effect was observed with waist and hip circumference (WC and HC). However, stratifying the WHR analysis by BMI identified an increased number of obese female knee OA cases with a lower WHR, when compared to obese female controls (57.4%, p=0.022) although both low and high WHR groups had significant OR for OA when compared to controls. In women, the cases (n=182) had smaller WC (mean 101.6±1.4) compared to the obese female controls (n=135) (mean 111.1±1.7) p<0.001 but similar HC (123.0±1.6 versus 120.1±1.6) respectively, p=0.015). The data suggest that having a greater WC or HC gives an increased risk (OR=1.7, P=0.01 and 1.5, p=0.045 respectively) for knee OA in this obese female group. Since WC reflects central obesity which is a feature of the metabolic syndrome we looked for an association with related co-morbidities: high WHR was associated with diabetes (OR=2.3 (1.1-5.3) p=0.035) and showed a trend towards an association with both hypertension and heart disease. In the high WHR group there was an increased association with nodal OA, defined clinically as nodes in at least two rays of each hand (OR=1.7 (1.0-3.0) p=0.063). A similar effect on sub-setting the WHR by BMI and associated increase in metabolic co-morbidities was observed in the overweight male knee OA group. Conclusions: Consistent with previous literature in other OA cohorts, BMI is a major risk factor for hip and knee OA in both men and women. We have found that WHR, WC and HC are not independent measures of BMI. However, sub-setting the WHR by BMI has indicated that the different body fat distribution in obese women may affect co-morbidities and degree of other joint involvement. The mechanism is uncertain but may be linked to systemic metabolic effects. were Caucasian, 52% had ≥ 2 comorbid conditions, and 52% had an annual household income ≤ $20,000 Canadian. 116 individuals (39.5%) reported persistent back problems. Those who reported persistent back problems were similar to those who did not in age, education, income, BMI, and level of social support. However, those with persistent back problems reported worse general health (p=0.009), more depressed mood (p=0.005), greater pain and functional disability (p<0.0001 for both), lower active and higher passive coping and pain catastrophizing scores (p=0.02, p=0.0002, and p=0.01, respectively). Adjusting for these differences, individuals with persistent back problems had reduced frequency of participation in everyday life tasks (p=0.002) but were similar to those without back problems in terms of their perceived limitation in capability to participate (p=0.51). 
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Conclusions
